🇺🇸 FDA

Intelligence Platform

Patents

Browse 13 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10889576

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10472357

Triazolopyridine compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10370366

Pyridazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10280160

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9944603

Compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9926315

Triazolopyridine compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855249

Isoxazole compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9790215

Pyridazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783529

Pyridazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9771327

Compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682969

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9573948

Triazolopyridine compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8937178

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted